AstraZeneca PLC (AZN)
NASDAQ: AZN · IEX Real-Time Price · USD
68.36
-0.17 (-0.25%)
Apr 18, 2024, 4:00 PM EDT - Market closed
AstraZeneca Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for AstraZeneca stock have an average target of 81.67, with a low estimate of 80 and a high estimate of 85. The average target predicts an increase of 19.47% from the current stock price of 68.36.
Analyst Consensus: Buy
* Price targets were last updated on Feb 12, 2024.
Analyst Ratings
The average analyst rating for AstraZeneca stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 1 | 2 | 2 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 5 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Deutsche Bank | Deutsche Bank | Strong Sell → Hold Upgrades n/a | Strong Sell → Hold | Upgrades | n/a | n/a | Apr 16, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $82 → $80 | Buy | Maintains | $82 → $80 | +17.03% | Feb 12, 2024 |
| Deutsche Bank | Deutsche Bank | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Feb 8, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $85 | Buy | Initiates | $85 | +24.34% | Jan 23, 2024 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 3, 2024 |
Financial Forecast
Revenue This Year
52.12B
from 45.81B
Increased by 13.77%
Revenue Next Year
55.93B
from 52.12B
Increased by 7.32%
EPS This Year
4.19
from 1.91
Increased by 120.16%
EPS Next Year
4.76
from 4.19
Increased by 13.51%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 54.6B | 59.2B | 63.7B | 66.8B | 70.7B |
| Avg | 52.1B | 55.9B | 58.7B | 60.5B | 63.3B |
| Low | 47.3B | 50.4B | 52.1B | 52.0B | 57.5B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 19.1% | 13.5% | 13.9% | 13.9% | 16.8% |
| Avg | 13.8% | 7.3% | 4.9% | 3.2% | 4.6% |
| Low | 3.2% | -3.4% | -6.9% | -11.3% | -5.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 4.58 | 5.81 | 6.10 | 6.39 | 6.62 |
| Avg | 4.19 | 4.76 | 5.15 | 5.83 | 6.01 |
| Low | 3.87 | 3.70 | 4.47 | 4.90 | 5.10 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 140.3% | 38.6% | 28.0% | 24.1% | 13.4% |
| Avg | 120.2% | 13.5% | 8.2% | 13.2% | 3.0% |
| Low | 103.2% | -11.8% | -6.0% | -5.0% | -12.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.